Alessandro Gronchi, MD, FSSO
Chair Sarcoma Service - Head of the Department of Surgery
Fondazione IRCCS Istituto Nazionale dei Tumori
Milano, Italy
Disclosure(s): Bayer HealthCare Pharmaceuticals Inc.: Advisor (Ongoing); Deciphera: Speaker (Ongoing); Eli Lilly & Company: Advisor (Terminated, January 1, 2020); Nanobiotix: Research Grant (Terminated, December 31, 2021); Novartis: Advisor (Terminated, November 5, 2022); pfizer: Advisor (Terminated, November 5, 2022); PharmaMar: Advisor (Ongoing), Research Grant (Ongoing); SpringWorks: Advisor (Ongoing)